1. Home
  2. HLMN vs NVAX Comparison

HLMN vs NVAX Comparison

Compare HLMN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.86

Market Cap

1.7B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.68

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
NVAX
Founded
1964
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.1B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
HLMN
NVAX
Price
$8.86
$6.68
Analyst Decision
Buy
Hold
Analyst Count
6
8
Target Price
$12.20
$9.75
AVG Volume (30 Days)
978.3K
3.2M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
388.43
N/A
EPS
0.19
2.07
Revenue
$1,536,647,000.00
$1,064,651,000.00
Revenue This Year
$7.97
$58.91
Revenue Next Year
$7.80
N/A
P/E Ratio
$47.69
$3.23
Revenue Growth
4.47
20.27
52 Week Low
$6.55
$5.01
52 Week High
$10.77
$11.55

Technical Indicators

Market Signals
Indicator
HLMN
NVAX
Relative Strength Index (RSI) 48.23 43.34
Support Level $8.81 $6.36
Resistance Level $9.21 $6.76
Average True Range (ATR) 0.26 0.22
MACD 0.02 0.05
Stochastic Oscillator 31.40 47.39

Price Performance

Historical Comparison
HLMN
NVAX

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S., Canada and Mexico.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: